William J. Gullick

12.5k total citations · 2 hit papers
154 papers, 10.3k citations indexed

About

William J. Gullick is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William J. Gullick has authored 154 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 79 papers in Molecular Biology and 70 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William J. Gullick's work include HER2/EGFR in Cancer Research (84 papers), Monoclonal and Polyclonal Antibodies Research (68 papers) and Glycosylation and Glycoproteins Research (31 papers). William J. Gullick is often cited by papers focused on HER2/EGFR in Cancer Research (84 papers), Monoclonal and Polyclonal Antibodies Research (68 papers) and Glycosylation and Glycoproteins Research (31 papers). William J. Gullick collaborates with scholars based in United Kingdom, United States and Italy. William J. Gullick's co-authors include Michael D. Waterfield, S A Prigent, Radhika Srinivasan, Jon Lindstrom, Nicholas R. Lemoine, Mark S. Berger, Christine M. Hughes, Laura Bazley, Thangarajan Rajkumar and Nancy E. Hynes and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

William J. Gullick

152 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

1989 523 citations C Wright, Brian Angus et al. PubMed profile →
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1988 507 citations Mark S. Berger, Gottfried W. Locher et al. PubMed profile →

Peers

Countries citing papers authored by William J. Gullick

Since Specialization

Citations

This map shows the geographic impact of William J. Gullick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Gullick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Gullick more than expected).

Fields of papers citing papers by William J. Gullick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Gullick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Gullick. The network helps show where William J. Gullick may publish in the future.

Co-authorship network of co-authors of William J. Gullick

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Gullick. A scholar is included among the top collaborators of William J. Gullick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Gullick. William J. Gullick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Localisation of Neuregulin 1-β3 to different sub-nuclear structures alters gene expression 2010 ·Experimental Cell Research ·Ming Wang, (unknown), William J. Gullick	4
2	Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity 2007 ·British Journal of Cancer ·C. M. McClelland, William J. Gullick	6
3	Characterization of the cell membrane-associated products of the Neuregulin 4 gene 2007 ·Oncogene ·Nandini V. L. Hayes, R. J. Newsam, Anthony J. Baines, William J. Gullick	28
4	A Recurrent Chromosome Breakpoint in Breast Cancer at the *NRG1* / *Neuregulin 1* / *Heregulin* Gene 2004 ·Cancer Research ·(unknown), Suet‐Feung Chin, Christophe Ginestier, Valérie‐Jeanne Bardou, José Adélaı̈de, N. Gopalakrishna Iyer, María J. García, Jessica C. Pole, Grace Callagy, Stephen M. Hewitt, William J. Gullick, Jocelyne Jacquemier, Carlos Caldas, Max Chaffanet, Daniel Birnbaum, Paul A. Edwards	73
5	A new model for ductal carcinoma in situ suggests strategies for treatment 2002 ·Breast Cancer Research ·William J. Gullick	6
6	The erbB family of receptors and their ligands: multiple targets for therapy. 2001 ·FUKUSHIMA JOURNAL OF MEDICAL SCIENCE ·David Salomon, William J. Gullick	28
7	Neuregulin 1-alpha expression in locally advanced breast cancer 2001 ·The Breast ·(unknown), (unknown), (unknown), K. Nirmala, Kodi S. Ravichandran, V. Shanta, Helen C. Hurst, William J. Gullick, Thangarajan Rajkumar	17
8	Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues 1996 ·International Journal of Cancer ·Luigi Panico, Antonio D’Antonio, Gaetano Salvatore, E. Mezza, Giampaolo Tortora, Michelino De Laurentiis, Sabino De Placido, Thomas J. Giordano, Maria J. Merino, David Salomon, William J. Gullick, Guido Pettinato, Stuart J. Schnitt, (unknown), Fortunato Ciardiello	4
9	EXPRESSION OF THE TYPE 1 TYROSINE KINASE GROWTH FACTOR RECEPTORS EGF RECEPTOR, c-erbB2 AND c-erbB3 IN BLADDER CANCER 1996 ·The Journal of Pathology ·Thangarajan Rajkumar, Gordon Stamp, Hardev Pandha, Jonathan Waxman, William J. Gullick	50
10	Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? 1992 ·European Journal of Cancer ·D M Barnes, (unknown), (unknown), Jiřina Bártková, RS Camplejohn, William J. Gullick	98
11	Growth factors in the gastrointestinal tract. 1992 ·Gut ·Nicholas R. Lemoine, Hing Y. Leung, William J. Gullick	15
12	c-erb B2 amplification and overexpression in human tumors 1991 ·Cancer treatment and research ·F. Lofts, William J. Gullick	35
13	Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia 1990 ·European Journal of Cancer and Clinical Oncology ·(unknown), Fiona S. Wyllie, Johan R. Lillehaug, (unknown), Christine M. Hughes, Rein Aasland, Jonathan Shaw, Jan Erik Varhaug, Christopher L. Brown, William J. Gullick, David Wynford‐Thomas	39
14	New developments in the molecular biology of breast cancer 1990 ·European Journal of Cancer and Clinical Oncology ·William J. Gullick	8
15	Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. breakdown → 1989 ·PubMed ·C Wright, Brian Angus, S Nicholson, J R C Sainsbury, John Cairns, William J. Gullick, Peter J. Kelly, Adrian L. Harris, C. H. W. Horne	523
16	c‐erbB‐2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study 1989 ·The Journal of Pathology ·Vincent Falck, William J. Gullick	85
17	c-erbB-2 oncoprotein expression in malignant and nonmalignant breast tissue 1989 ·Irish Journal of Medical Science (1971 -) ·Amanda McCann, Paul A. Johnston, P. Dervan, William J. Gullick, D. N. Carney	13
18	Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. breakdown → 1988 ·PubMed ·Mark S. Berger, Gottfried W. Locher, Susanne Saurer, William J. Gullick, Michael D. Waterfield, Bernd Groner, Nancy E. Hynes	507
19	Production and characterization of monoclonal antibodies to the c-erbB-2 proto-oncogene protein using a synthetic peptide immunogen 1988 ·Biochemical Society Transactions ·Nadia L. Tuzi, Deon J. Venter, (unknown), Christopher Dean, William J. Gullick	2
20	The structure and function of the epidermal growth factor receptor studied by using antisynthetic peptide antibodies 1985 ·Proceedings of the Royal Society of London. Series B, Biological sciences ·William J. Gullick, Julian Downward, Peter J. Parker, Nigel Whittle, Richard Kris, Joseph Schlessinger, A. Ullrich, Michael D. Waterfield	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact